{"id":2162,"date":"2015-12-10T14:06:28","date_gmt":"2015-12-10T14:06:28","guid":{"rendered":"http:\/\/drupal.test\/projects\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/"},"modified":"2022-07-26T15:26:34","modified_gmt":"2022-07-26T19:26:34","slug":"programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles","status":"publish","type":"project","link":"https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/","title":{"rendered":"Programme des anticorps synth\u00e9tiques : r\u00e9actifs commerciaux et  th\u00e9rapies nouvelles"},"content":{"rendered":"<p>Le cancer dans la mire. Au cours de la derni\u00e8re d\u00e9cennie, des anticorps humains se sont r\u00e9v\u00e9l\u00e9 des candidats tr\u00e8s prometteurs pour la lutte contre le cancer et d\u2019autres grandes maladies. Gr\u00e2ce au financement de G\u00e9nome Canada, des chercheurs utilisent une technologie d\u2019avant\u00adgarde pour mettre au point des anticorps qui ciblent des prot\u00e9ines associ\u00e9es au cancer.<\/p>\n<p>Des chercheurs du Toronto Recombinant Antibody Technology Centre travaillent en collaboration avec ceux du programme de th\u00e9rapies s\u00e9lectives de l\u2019Ontario Institute for Cancer Research afin de mettre au point un programme de production \u00e0 grande \u00e9chelle d\u2019anticorps.<\/p>\n<p>Ce projet aura des r\u00e9percussions importantes sur la recherche fondamentale en biologie du cancer, multipliera les possibilit\u00e9s de th\u00e9rapies anticanc\u00e9reuses et cr\u00e9era des d\u00e9bouch\u00e9s commerciaux. Les chercheurs examinent \u00e9galement les r\u00e9percussions \u00e9thiques de la production \u00e0 grande \u00e9chelle d\u2019anticorps. Ces questions sont en particulier \u00e9tudi\u00e9es dans le contexte de la justice distributive \u2013 le partage \u00e9quitable de rares ressources entre tous les groupes socio\u00e9conomiques.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le cancer dans la mire. Au cours de la derni\u00e8re d\u00e9cennie, des anticorps humains se sont r\u00e9v\u00e9l\u00e9 des candidats tr\u00e8s prometteurs pour la lutte contre le cancer et d\u2019autres grandes maladies. Gr\u00e2ce au financement de G\u00e9nome Canada, des chercheurs utilisent une technologie d\u2019avant\u00adgarde pour mettre au point des anticorps qui ciblent des prot\u00e9ines associ\u00e9es au [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[93],"genome-competitions":[225],"project-sector":[],"genome_centres":[108],"class_list":["post-2162","project","type-project","status-publish","hentry","project-categories-large-scale-science-fr","genome-competitions-concours-2010-projets-de-recherche-appliquee-a-grande-echelle-volet-multisectoriel","genome_centres-ontario-genomics-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Programme des anticorps synth\u00e9tiques : r\u00e9actifs commerciaux et th\u00e9rapies nouvelles - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Programme des anticorps synth\u00e9tiques : r\u00e9actifs commerciaux et th\u00e9rapies nouvelles - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Le cancer dans la mire. Au cours de la derni\u00e8re d\u00e9cennie, des anticorps humains se sont r\u00e9v\u00e9l\u00e9 des candidats tr\u00e8s prometteurs pour la lutte contre le cancer et d\u2019autres grandes maladies. Gr\u00e2ce au financement de G\u00e9nome Canada, des chercheurs utilisent une technologie d\u2019avant\u00adgarde pour mettre au point des anticorps qui ciblent des prot\u00e9ines associ\u00e9es au [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T19:26:34+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\\\/\",\"name\":\"Programme des anticorps synth\u00e9tiques : r\u00e9actifs commerciaux et th\u00e9rapies nouvelles - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2015-12-10T14:06:28+00:00\",\"dateModified\":\"2022-07-26T19:26:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Programme des anticorps synth\u00e9tiques : r\u00e9actifs commerciaux et th\u00e9rapies nouvelles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Programme des anticorps synth\u00e9tiques : r\u00e9actifs commerciaux et th\u00e9rapies nouvelles - GenomeCanada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/","og_locale":"fr_FR","og_type":"article","og_title":"Programme des anticorps synth\u00e9tiques : r\u00e9actifs commerciaux et th\u00e9rapies nouvelles - GenomeCanada","og_description":"Le cancer dans la mire. Au cours de la derni\u00e8re d\u00e9cennie, des anticorps humains se sont r\u00e9v\u00e9l\u00e9 des candidats tr\u00e8s prometteurs pour la lutte contre le cancer et d\u2019autres grandes maladies. Gr\u00e2ce au financement de G\u00e9nome Canada, des chercheurs utilisent une technologie d\u2019avant\u00adgarde pour mettre au point des anticorps qui ciblent des prot\u00e9ines associ\u00e9es au [&hellip;]","og_url":"https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T19:26:34+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/","url":"https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/","name":"Programme des anticorps synth\u00e9tiques : r\u00e9actifs commerciaux et th\u00e9rapies nouvelles - GenomeCanada","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/#website"},"datePublished":"2015-12-10T14:06:28+00:00","dateModified":"2022-07-26T19:26:34+00:00","breadcrumb":{"@id":"https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomecanada.ca\/fr\/project\/programme-des-anticorps-synthetiques-reactifs-commerciaux-et-therapies-nouvelles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Programme des anticorps synth\u00e9tiques : r\u00e9actifs commerciaux et th\u00e9rapies nouvelles"}]},{"@type":"WebSite","@id":"https:\/\/genomecanada.ca\/fr\/#website","url":"https:\/\/genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/2162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/2162\/revisions"}],"wp:attachment":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=2162"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=2162"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=2162"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=2162"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=2162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}